The Effects of Ursodeoxycholic Acid Treatment for Intrahepatic Cholestasis of Pregnancy on Maternal and Fetal Outcomes: A Meta-Analysis Including Non-Randomized Studies

Journal of Obstetrics and Gynaecology Canada

Volumn 36, Issue 7, 2014, Pages 632-641

  Grand'Maison, Sophie ^a   Durand, Madeleine ^a   Mahone, Michèle ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Intrahepatic cholestasis of pregnancy; Maternal; Prematurity; Treatment; Ursodeoxycholic acid

Indexed keywords

COLESTYRAMINE; DEXAMETHASONE; PLACEBO; S ADENOSYLMETHIONINE; URSODEOXYCHOLIC ACID;

ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; FETUS OUTCOME; HUMAN; HYPERTRANSAMINASEMIA; INTRAHEPATIC CHOLESTASIS; INTRAHEPATIC CHOLESTASIS OF PREGNANCY; LIVER FUNCTION TEST; MECONIUM ASPIRATION; META ANALYSIS; NEWBORN INTENSIVE CARE; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURITY; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STILLBIRTH; CHOLESTASIS, INTRAHEPATIC; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFECTS; FEMALE; FETUS; PREGNANCY; PREGNANCY COMPLICATIONS;

CHOLESTASIS, INTRAHEPATIC; FEMALE; FETUS; HUMANS; NON-RANDOMIZED CONTROLLED TRIALS AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; URSODEOXYCHOLIC ACID;

EID: 84922319096     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30544-2     Document Type: Article

References (31)

1. Joshi D., James A., Quaglia A., Westbrook R.H., Heneghan M.A. Liver disease in pregnancy. Lancet 2010, 375:594-605.
2. Hilaire S. Cholestase gravidique: le point en 2011. Hépato-gastro 2011, 18(3):277-282.
3. Bacq Y. Liver diseases unique to pregnancy: a 2010 update. Clin Res Hepatol Gastroenteol 2011, 35(3):182-193.
4. Mays J.K. The active management of intrahepatic cholestasis of pregnancy. Curr Opin Obstet Gynecol 2010, 22(2):100-103.
5. Beuers U., Pusl T. Intrahepatic cholestasis of pregnancy-a heterogeneous group of pregnancy-related disorders?. Hepatology 2006, 43(4):647-649.
6. Fisk N.M., Bye W.B., Storey G.N. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital. Aust N Z J Obstet Gynaecol 1988, 28:172-176.
7. Alsulyman O.M., Ouzounian J.G., Ames-Castro M., Goodwin T.M. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996, 175:957-960.
8. Glantz A., Marschall H.U., Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004, 40:467-474.
9. Roncaglia N., Arreghini A., Locatelli A., Bellini P., Andreotti C., Ghidini A. Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 2002, 100(2):167-170.
10. Diaferia A., Nicastri P.L., Tartagni M., Loizzi P., Lacovizzi C., Di Leo A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 1996, 52(2):133-140.
11. Burrows R.F., Clavisi O., Burrows E. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst Rev 2001, 4.
12. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
13. Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. and the.
14. Harris R., Helfand M., Woolf S., Lohr K., Mulrow C., Teutsch S., et al. Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med 2001, 20(3S):21-35.
15. Ioannidis J., Patsopoulos N., Rothstein H. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 2008, 36:1413-1415.
16. Glantz A., Marschall H.U., Lammert F., Mattson L.A. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005, 42(6):1399-1405.
17. Chappell L.C., Gurung V., Seed P.T., Chambers J., Williamson C., Thornton J.G. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012, 344.
18. Binder T., Salaj P., Zima T., Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006, 34(5):383-391.
19. Roncaglia N., Locatelli A., Arreghini A., Assi F., Cameroni I., Pezzulo J.C., et al. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-1 -methionine in the treatment of gestational cholestais. BJOG 2004, 111(1):17-21.
20. Kondrackiene J., Beuers U., Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005, 129(3):894-901.
21. Palma J., Reyes H., Ribalta J., Hernandez I., Sandoval L., Almuna R., et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997, 27(6):1022-1028.
22. Floreani A., Paternoster D., Melis A., Grella P.V. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur J Obstet Gynecol Reprod Biol 1996, 67(2):109-113.
23. Nicastri P.L., Diaferia A., Tartagni M., Loizzi P., Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1998, 105(11):1205-1207.
24. Liu Y., Qiao F., Liu H., Liu D. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. J Huazhong U Sci Tech 2006, 26(3):350-352.
25. Isla C.R., Cappelletti C.A., Tielli G., Ameigeiras B., Caifa H.M., Dunaiewsky A., et al. Value of ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy [abstract]. American Association for the Study of Liver Diseases 1996, 110:1219.
26. Zapata R., Sandoval L., Palma J., Hernandez I., Ribalta J., Reyes H., et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int 2005, 25(3):548-554.
27. Mazzella G., Rizzo N., Azzaroli F., Simoni P., Bovicelli L., Miracolo A., et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001, 33(3):504-508.
28. Milkiewicz P., Gallagher R., Chambers J., Eggington E., Weaver J., Elias E. Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment. J Gastroenterol Hepatol 2003, 18(11):1283-1286.
29. Rodrigues C.M., Marin J.J., Brites D. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment. Gut 1999, 45(3):446-452.
30. Laifer S.A., Stiller R.J., Siddiqui D.S., Dunston-Boone G., Whetham J.C. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 2001, 10(2):131-135.
31. Brites D., Rodrigues C.M. Elevated levels of bile acids in colostrum of patients with cholestatis of pregnancy are decreased following ursodeoxycholic acid therapy. J Hepatol 1998, 29(5):743-751.